×
Please click
here
if you are not redirected within a few seconds.
All
News
Images
Videos
Maps
Shopping
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
Amarin Applauds HealthyWomen's Citizen's Petition Urging
GlobeNewswire
DUBLIN, Ireland and BRIDGEWATER, N.J., April 24, 2024 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN) today announced its support...
4 days ago
Teva, like Hikma, accuses Amarin of hoarding Vascepa ingredient
Fierce Pharma
In a new lawsuit, Teva flagged Amarin's “anti-competitive conduct to prevent and delay generic competition” to Vascepa—a fish-oil-derived...
1 month ago
Fed. Circ. Seems Ready To Revive Amarin's Skinny Label Suit
Law360
A Federal Circuit panel seemed wary Tuesday of a Delaware federal judge's decision to throw out Amarin Pharma Inc.'s infringement suit over...
4 weeks ago
Why Amarin Stock Skyrocketed Today
The Motley Fool
Key Points. Amarin announced better-than-expected fourth-quarter results on Wednesday. The biopharmaceuticals company also announced a $50...
3 months ago
Amarin (AMRN) Up 7% on Intellectual Property Wins in Europe
Yahoo Finance
Amarin (AMRN) secures a new patent for Vazkepa in Europe, which extends its exclusivity for eight more years. It achieves success in...
3 weeks ago
Amarin Shareholders Show Strong Support at Annual Meeting - TipRanks.com
Tipranks
Amarin Corporation Plc (AMRN) just unveiled an announcement. At the Company's Annual Meeting, shareholders congregated to cast their votes...
6 days ago
Teva Hits Amarin With Antitrust Lawsuit Over Generic Competition
Bloomberg Law News
Teva Pharmaceuticals is challenging Amarin Pharma Inc., alleging it entered exclusive agreements with active pharmaceutical ingredient...
1 month ago
'That's A Much Broader Statement': Hikma Grilled In Amarin Vascepa Skinny-Label Appeal
Generics Bulletin
Hikma may have succeeded in dismissing Amarin's induced infringement claim against the firm over Hikma's skinny label generic Vascepa in the...
2 weeks ago
Amarin Corp. (AMRN) Issues Update on VAZKEPA Intellectual Property Portfolio in Europe
StreetInsider
The Decision to Grant from the EPO indicates a grant date of April 24, 2024, for a new Amarin patent containing claims covering VAZKEPA in...
3 weeks ago
Amarin Corporation: Small Signs Of Recovery May Not Be Enough
Seeking Alpha
Amarin is going through a turbulent period with a strong contraction in revenue and margins. See why I feel AMRN stock is overvalued and...
2 weeks ago